The production of more useful monoclonal antibodies 2. The use of somatic-cell genetic and recombinant-DNA technology to tailor-make monoclonal antibodies

Hector L. Agulla, Roberta R. Pollock, Gad Spira, Matthew D. Scharff

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

In last month's issue1 Matthew Scharff and his colleagues discussed recent improvements in the technique of making monoclonal antibodies by cell fusion. However, not all the monoclonal antibodies generated by hybridoma technology have all of the properties required for a particular task. This second part of a two-part review deals with ways in which these first-generation reagents can be improved by identifying somatic-cell mutants with the desired properties or by engineering new and even novel molecules using recombinant DNA technology.

Original languageEnglish (US)
Pages (from-to)380-383
Number of pages4
JournalImmunology Today
Volume7
Issue number12
DOIs
StatePublished - 1986

Fingerprint

Recombinant DNA
Monoclonal Antibodies
Technology
Cell Fusion
Hybridomas

ASJC Scopus subject areas

  • Immunology

Cite this

The production of more useful monoclonal antibodies 2. The use of somatic-cell genetic and recombinant-DNA technology to tailor-make monoclonal antibodies. / Agulla, Hector L.; Pollock, Roberta R.; Spira, Gad; Scharff, Matthew D.

In: Immunology Today, Vol. 7, No. 12, 1986, p. 380-383.

Research output: Contribution to journalArticle

@article{1fc49975dad246fea96b7538c30dbf94,
title = "The production of more useful monoclonal antibodies 2. The use of somatic-cell genetic and recombinant-DNA technology to tailor-make monoclonal antibodies",
abstract = "In last month's issue1 Matthew Scharff and his colleagues discussed recent improvements in the technique of making monoclonal antibodies by cell fusion. However, not all the monoclonal antibodies generated by hybridoma technology have all of the properties required for a particular task. This second part of a two-part review deals with ways in which these first-generation reagents can be improved by identifying somatic-cell mutants with the desired properties or by engineering new and even novel molecules using recombinant DNA technology.",
author = "Agulla, {Hector L.} and Pollock, {Roberta R.} and Gad Spira and Scharff, {Matthew D.}",
year = "1986",
doi = "10.1016/0167-5699(86)90031-9",
language = "English (US)",
volume = "7",
pages = "380--383",
journal = "Trends in Immunology",
issn = "1471-4906",
publisher = "Elsevier Limited",
number = "12",

}

TY - JOUR

T1 - The production of more useful monoclonal antibodies 2. The use of somatic-cell genetic and recombinant-DNA technology to tailor-make monoclonal antibodies

AU - Agulla, Hector L.

AU - Pollock, Roberta R.

AU - Spira, Gad

AU - Scharff, Matthew D.

PY - 1986

Y1 - 1986

N2 - In last month's issue1 Matthew Scharff and his colleagues discussed recent improvements in the technique of making monoclonal antibodies by cell fusion. However, not all the monoclonal antibodies generated by hybridoma technology have all of the properties required for a particular task. This second part of a two-part review deals with ways in which these first-generation reagents can be improved by identifying somatic-cell mutants with the desired properties or by engineering new and even novel molecules using recombinant DNA technology.

AB - In last month's issue1 Matthew Scharff and his colleagues discussed recent improvements in the technique of making monoclonal antibodies by cell fusion. However, not all the monoclonal antibodies generated by hybridoma technology have all of the properties required for a particular task. This second part of a two-part review deals with ways in which these first-generation reagents can be improved by identifying somatic-cell mutants with the desired properties or by engineering new and even novel molecules using recombinant DNA technology.

UR - http://www.scopus.com/inward/record.url?scp=0022908970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022908970&partnerID=8YFLogxK

U2 - 10.1016/0167-5699(86)90031-9

DO - 10.1016/0167-5699(86)90031-9

M3 - Article

VL - 7

SP - 380

EP - 383

JO - Trends in Immunology

JF - Trends in Immunology

SN - 1471-4906

IS - 12

ER -